BioStock: Chordate Medical trains leading UK neurology hospital

On October 6-7, Chordate Medical exhibited its product Ozilia Migraine at a neurology symposium held at the large hospital The Walton Centre in Liverpool. In connection with the event, the company also had the opportunity to provide a separate training on the company’s migraine treatment for nurses and specialist doctors. The group initially intends to use the treatment in their private practice, says the company’s CEO Anders Weilandt in an interview. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/10/chordate-medical-trains-leading-uk-neurology-hospital/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se